Skip to main content
Nexphoria

Research Tools

Injection Site Diagram

Interactive body diagram with needle length, angle, volume limits, and rotation advice for each injection zone. Click any highlighted area to view technique details.

Front

Abdomen(R)Abdomen(L)Thigh(R)Thigh(L)Deltoid(R)Deltoid(L)

Back

Glute(R)Glute(L)

Click a highlighted zone to view details

Zones

Select a zone to view details

Click any highlighted area on the diagram or a zone button to see needle length, angle, volume limits, technique, and common mistakes.

SC vs IM: Key Differences

Most research peptides are administered subcutaneously (SC). Intramuscular (IM) is used for larger volumes or compounds requiring faster peak absorption.

Subcutaneous (SC)

Inject into the fatty layer between skin and muscle
29–31G × 4–6 mm insulin-type needle
45–90° angle depending on tissue thickness
Volume: up to 1 mL per injection site
Slower, sustained absorption — ideal for depot formation
Used by: BPC-157, TB-500, GHK-Cu, semaglutide, tirzepatide, ipamorelin, most peptides

Intramuscular (IM)

Inject directly into muscle tissue
22–25G × 16–38 mm needle (length varies by site and tissue depth)
90° angle to skin surface
Volume: deltoid ≤1 mL; vastus lateralis ≤2 mL; ventrogluteal ≤3 mL
Faster absorption due to rich muscle vasculature
Used for: large-volume injections (NAD+), some TB-500 protocols, or when SC volume limit is exceeded

Rotation Strategy

8-Site Rotation Protocol

For compounds requiring daily injection (BPC-157, ipamorelin, sermorelin, NAD+), an 8-site rotation allows each site 7 days of recovery before re-use.

  • 1.Right Abdomen
  • 2.Right Anterior Thigh
  • 3.Right Deltoid (if IM and low-volume)
  • 4.Right Ventrogluteal (if IM)
  • 5.Left Abdomen
  • 6.Left Anterior Thigh
  • 7.Left Deltoid
  • 8.Left Ventrogluteal
8-SITE ROTATION (one suggested sequence)1Abd R2Thigh R3Delt R4Glute R5Abd L6Thigh L7Delt L8Glute L

Needle Size Reference

GaugeLengthRouteBest ForFlow Rate
29–31G4–6 mmSC — SubcutaneousAll peptides, daily SC injections (BPC-157, ipamorelin, semaglutide)Slow — ideal for SC depot
27–28G6–12 mmSC — SubcutaneousSlightly larger SC volumes (0.5–1 mL), subcutaneous belly fatModerate
25–26G16 mm (⅝")IM — IntramuscularDeltoid IM, thin patients, standard IMModerate
23–24G25 mm (1")IM — IntramuscularThigh IM (vastus lateralis), average tissue depthModerate–fast
21–22G38 mm (1.5")IM — IntramuscularVentrogluteal IM, large volume injections (NAD+), larger subjectsFast

Research Use Only — Disclaimer

This diagram is intended for qualified researchers and educational reference only. All information is provided for in vitro / in vivo preclinical research study design. This tool does not constitute medical advice, clinical guidance, or instruction for human self-administration. Nexphoria products are sold strictly for laboratory research purposes and are not approved for human use, diagnosis, treatment, or prevention of any disease or condition.

RUOFor Research Use Only (RUO) — Not for human consumption, clinical use, diagnostic use, or veterinary applications.